ABIONYX Pharma SA (ABNX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

OSE Immunotherapeutics SA

Cellectis SA

Sensorion SA

Genfit SA

DBV Technologies SA

Adocia SA

MedinCell SA

Maat Pharma SA

Innate Pharma SA

ABIONYX Pharma SA

Valerio Therapeutics SA

Why is ABIONYX Pharma SA ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is ABIONYX Pharma SA for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

ABIONYX Pharma SA

190.23%

0.98

84.89%

France CAC 40

0.34%

-0.10

17.53%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

39.75%

EBIT Growth (5y)

-184.75%

EBIT to Interest (avg)

-5.48

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.24

Sales to Capital Employed (avg)

0.41

Tax Ratio

19.86%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

22.04

EV to EBIT

-19.76

EV to EBITDA

-21.69

EV to Capital Employed

23.79

EV to Sales

27.49

PEG Ratio

Dividend Yield

ROCE (Latest)

-120.36%

ROE (Latest)

-84.95%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at EUR -2.31 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 2.43 times

RAW MATERIAL COST(Y)

Fallen by -428.63% (YoY

-10What is not working for the Company

INTEREST(HY)

At EUR 0.06 MM has Grown at 38.1%

ROCE(HY)

Lowest at -62.4%

NET SALES(Q)

Lowest at EUR 2.12 MM

OPERATING PROFIT(Q)

Lowest at EUR -2.77 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -130.77 %

PRE-TAX PROFIT(Q)

Lowest at EUR -2.99 MM

NET PROFIT(Q)

Lowest at EUR -2.31 MM

Here's what is working for ABIONYX Pharma SA

Debtors Turnover Ratio

Highest at 2.43 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -428.63% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for ABIONYX Pharma SA

Interest

At EUR 0.06 MM has Grown at 38.1%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

Net Sales

Lowest at EUR 2.12 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (EUR MM)

Operating Profit

Lowest at EUR -2.77 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (EUR MM)

Operating Profit Margin

Lowest at -130.77 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at EUR -2.99 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (EUR MM)

Net Profit

Lowest at EUR -2.31 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (EUR MM)